Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-21-005047
Filing Date
2021-04-22
Accepted
2021-04-22 17:30:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 33200
2 filename2.txt TEXT-EXTRACT 9113
  Complete submission text file 0000000000-21-005047.txt   55475
Mailing Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Filed for) CIK: 0001662244 (see all company filings)

EIN.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations